A Randomized Phase 3 Study Comparing P2B001 to Its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease
MOVEMENT DISORDERS(2024)
关键词
Parkinson's disease,pramipexole,rasagiline
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要